Anti-IL-6 antibodies, compositions, methods and uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 16, 2010
Issued Date -
N/A
app pub date -
Oct 30, 2007
filing date -
Nov 14, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully